Global Ganja Report

Around the world, mothers are on the frontlines of demanding legal access to cannabis products for their children who suffer from epilepsy and other ailments. Often, these courageous moms have risked their freedom to provide medicine for their offspring. Sometimes they have actually shamed the authorities into changing the law—but still face the prospect of prison time.

Turned down by the British government when they requested permission to use cannabis oil, the family of a child epilepsy sufferer personally delivered a petition with thousands of signatures to 10 Downing Street. They were backed up by members of parliament and the famous actor Sir Patrick Stewart. Charges of hypocrisy on the part of government were brought into sharp focus by revelations that the Home Office minister—ultimately responsible for the decision to turn down the request—is married to a businessman who oversees massive cultivation under contract to GW Pharmaceuticals.

Several bills now pending before the Colorado state house will further shape what the legal cannabis economy will look like in the Centennial State—for better or for worse. While some of these measures would mean a freer atmosphere both for "recreational" and medicinal users, others may portend greater big-money control of the fast-growing industry.

A United Nations study brings back the surprise finding that the world's biggest producer of legal cannabis is Great Britain. The answer to this seeming anomaly lies in one UK-based multinational corporation with industrial-scale grow operations for production of pharmaceuticals.

A new study by the Psychedelic Research Group at Imperial College London has reached astonishing findings about the therapeutic potentialities of psilocybin, the psychoactive chemical in magic mushrooms. A first report from the group's study, released in October, indicated that psilocybin can "reset" the brains of depressed patients. A second report, just published in the Journal of Psychopharmacology, indicates that the psychedelic agent may even affect political views.

Here's some news that should surprise nobody. International efforts to suppress the trade in a psychoactive plant are failing to do so, but are jacking up the social costs of its use—which might be quite negligible if the stuff weren't illegal. In this case we're talking about khat, the mildly stimulating leaf that is chewed socially in the Horn of Africa and its immigrant diaspora. It was sold openly at groceries and eateries in London's African communities until Britain finally banned the stuff in of 2014, following the example of the United States (of course). At that time, it became a Class C substance under the UK Misuse of Drugs Act. By way of comparison, cannabis is in the more restrictive Class B—although between 2004 and 2008 pot was placed in Class C, and there is an initiative to have it removed from the classification system altogether.

A welcome blow is reported against the deeply ingrained stigma that attaches even to users of basically harmless drugs like cannabis that happen to be illegal. The Global Commission on Drug Policy—a body with dissident views but made up of prestigious elder statesmen and world leaders, so it can't be readily ignored—has just issued a statement calling on policymakers and the media to avoid using terms such as "drug user," "addict" and "junkie." The report includes a checklist of what terms should be eschewed or embraced to avoid language portraying people who use drugs as "physically inferior or morally flawed."

The Balkan country of Albania, trying to live down its pariah status as Europe's top cannabis producer, has cracked down hard in recent years, sparking instances of armed resistance from peasant growers. But despite repeated declarations that the country is "marijuana-free," the issue won't go away—and is coming to the fore once again as Albania seeks to join the European Union. The latest to lecture Albanian leaders is US ambassador Donald Lu, who this month warned that the country's criminal networks remain intact.